| Agranulocytosis | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Anaemia | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG00020 events20 affected8,574 at risk
- EG00130 events28 affected8,569 at risk
|
| Anaemia of chronic disease | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Anaemia vitamin b12 deficiency | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Coagulopathy | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Disseminated intravascular coagulation | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Elephantiasis | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Febrile neutropenia | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Haemorrhagic anaemia | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Hilar lymphadenopathy | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Immune thrombocytopenic purpura | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Iron deficiency anaemia | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG00014 events12 affected8,574 at risk
- EG00118 events18 affected8,569 at risk
|
| Leukocytosis | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Lymphadenopathy | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Lymphadenopathy mediastinal | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Microcytic anaemia | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Neutropenia | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Normocytic anaemia | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pancytopenia | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Plasmacytosis | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Splenic cyst | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Splenic infarction | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Thrombocytopenia | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0014 events3 affected8,569 at risk
|
| Thrombocytopenic purpura | Blood and lymphatic system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Acute cardiac event | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Acute coronary syndrome | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00022 events17 affected8,574 at risk
- EG00133 events31 affected8,569 at risk
|
| Acute left ventricular failure | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00022 events16 affected8,574 at risk
- EG00123 events17 affected8,569 at risk
|
| Acute myocardial infarction | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG000293 events265 affected8,574 at risk
- EG001264 events233 affected8,569 at risk
|
| Adams-stokes syndrome | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Angina pectoris | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG000178 events154 affected8,574 at risk
- EG001175 events159 affected8,569 at risk
|
| Angina unstable | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG000349 events271 affected8,574 at risk
- EG001332 events269 affected8,569 at risk
|
| Aortic valve calcification | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Aortic valve disease | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Aortic valve disease mixed | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Aortic valve incompetence | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Aortic valve stenosis | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00010 events10 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Arrhythmia | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Arteriosclerosis coronary artery | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG00121 events16 affected8,569 at risk
|
| Atrial fibrillation | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG000138 events117 affected8,574 at risk
- EG001177 events139 affected8,569 at risk
|
| Atrial flutter | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00025 events21 affected8,574 at risk
- EG00144 events34 affected8,569 at risk
|
| Atrial tachycardia | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Atrial thrombosis | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Atrioventricular block | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0017 events7 affected8,569 at risk
|
| Atrioventricular block complete | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00019 events19 affected8,574 at risk
- EG00114 events14 affected8,569 at risk
|
| Atrioventricular block second degree | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00010 events10 affected8,574 at risk
- EG0017 events7 affected8,569 at risk
|
| Bifascicular block | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Bradyarrhythmia | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Bradycardia | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00017 events16 affected8,574 at risk
- EG00122 events21 affected8,569 at risk
|
| Bundle branch block left | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Bundle branch block right | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Cardiac arrest | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00034 events33 affected8,574 at risk
- EG00132 events31 affected8,569 at risk
|
| Cardiac asthma | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0018 events5 affected8,569 at risk
|
| Cardiac disorder | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Cardiac failure | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG000199 events147 affected8,574 at risk
- EG001252 events188 affected8,569 at risk
|
| Cardiac failure acute | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00025 events22 affected8,574 at risk
- EG00139 events31 affected8,569 at risk
|
| Cardiac failure chronic | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00014 events12 affected8,574 at risk
- EG00123 events20 affected8,569 at risk
|
| Cardiac failure congestive | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG000177 events121 affected8,574 at risk
- EG001205 events147 affected8,569 at risk
|
| Cardiac tamponade | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Cardiac ventricular thrombosis | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Cardio-respiratory arrest | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00012 events12 affected8,574 at risk
- EG00111 events11 affected8,569 at risk
|
| Cardiogenic shock | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00019 events19 affected8,574 at risk
- EG00116 events13 affected8,569 at risk
|
| Cardiomegaly | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cardiomyopathy | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0008 events7 affected8,574 at risk
- EG0018 events8 affected8,569 at risk
|
| Cardiomyopathy acute | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Cardiopulmonary failure | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0017 events7 affected8,569 at risk
|
| Cardiovascular disorder | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cardiovascular insufficiency | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Chronic left ventricular failure | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Chronotropic incompetence | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Conduction disorder | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Congestive cardiomyopathy | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Cor pulmonale | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Coronary artery aneurysm | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Coronary artery disease | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG000113 events106 affected8,574 at risk
- EG00187 events84 affected8,569 at risk
|
| Coronary artery occlusion | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0009 events9 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Coronary artery stenosis | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00013 events12 affected8,574 at risk
- EG00123 events22 affected8,569 at risk
|
| Coronary artery thrombosis | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Coronary ostial stenosis | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Diastolic dysfunction | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Dressler's syndrome | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Extrasystoles | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Heart valve incompetence | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Heart valve stenosis | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hypertensive heart disease | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Ischaemic cardiomyopathy | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00010 events10 affected8,574 at risk
- EG00118 events18 affected8,569 at risk
|
| Left ventricular dysfunction | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Left ventricular failure | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00015 events11 affected8,574 at risk
- EG00113 events13 affected8,569 at risk
|
| Mitral valve incompetence | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0008 events7 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Mitral valve stenosis | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Myocardial infarction | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG000104 events96 affected8,574 at risk
- EG001111 events108 affected8,569 at risk
|
| Myocardial ischaemia | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00049 events47 affected8,574 at risk
- EG00161 events54 affected8,569 at risk
|
| Myocarditis | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Nodal arrhythmia | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Palpitations | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Pericardial effusion | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Pericarditis | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00012 events8 affected8,574 at risk
- EG0015 events4 affected8,569 at risk
|
| Postinfarction angina | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Prinzmetal angina | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pulseless electrical activity | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Rheumatic heart disease | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Right ventricular failure | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Sinus arrest | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Sinus bradycardia | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Sinus node dysfunction | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00014 events14 affected8,574 at risk
- EG00114 events13 affected8,569 at risk
|
| Sinus tachycardia | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Supraventricular tachycardia | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00012 events12 affected8,574 at risk
- EG0017 events6 affected8,569 at risk
|
| Tachyarrhythmia | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Tachycardia | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0006 events5 affected8,574 at risk
- EG0016 events5 affected8,569 at risk
|
| Torsade de pointes | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Tricuspid valve incompetence | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Trifascicular block | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Ventricular arrhythmia | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0014 events2 affected8,569 at risk
|
| Ventricular extrasystoles | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Ventricular failure | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Ventricular fibrillation | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG0008 events8 affected8,574 at risk
- EG00111 events9 affected8,569 at risk
|
| Ventricular tachycardia | Cardiac disorders | MedDRA 21 | Systematic Assessment | | - EG00023 events19 affected8,574 at risk
- EG00121 events15 affected8,569 at risk
|
| Adenomatous polyposis coli | Congenital, familial and genetic disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Congenital hepatobiliary anomaly | Congenital, familial and genetic disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Diverticulitis meckel's | Congenital, familial and genetic disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Heart disease congenital | Congenital, familial and genetic disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Hydrocele | Congenital, familial and genetic disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Hypertrophic cardiomyopathy | Congenital, familial and genetic disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Vitello-intestinal duct remnant | Congenital, familial and genetic disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Acute vestibular syndrome | Ear and labyrinth disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Deafness neurosensory | Ear and labyrinth disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hypoacusis | Ear and labyrinth disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Sudden hearing loss | Ear and labyrinth disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Tinnitus | Ear and labyrinth disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Vertigo | Ear and labyrinth disorders | MedDRA 21 | Systematic Assessment | | - EG00011 events11 affected8,574 at risk
- EG00113 events12 affected8,569 at risk
|
| Vertigo labyrinthine | Ear and labyrinth disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Vertigo positional | Ear and labyrinth disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0018 events8 affected8,569 at risk
|
| Vestibular ataxia | Ear and labyrinth disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Vestibular disorder | Ear and labyrinth disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Adrenal insufficiency | Endocrine disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Adrenal mass | Endocrine disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Adrenomegaly | Endocrine disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Basedow's disease | Endocrine disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Goitre | Endocrine disorders | MedDRA 21 | Systematic Assessment | | - EG0007 events7 affected8,574 at risk
- EG0018 events8 affected8,569 at risk
|
| Hyperadrenalism | Endocrine disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hyperparathyroidism | Endocrine disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hyperparathyroidism primary | Endocrine disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hypopituitarism | Endocrine disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Thyroid mass | Endocrine disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Toxic nodular goitre | Endocrine disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Amaurosis | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Amaurosis fugax | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Amblyopia | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Astigmatism | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Blindness transient | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Cataract | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG00031 events28 affected8,574 at risk
- EG00132 events26 affected8,569 at risk
|
| Cataract nuclear | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Cataract subcapsular | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Corneal deposits | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Dacryostenosis acquired | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Diabetic retinal oedema | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Diabetic retinopathy | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Diplopia | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Endocrine ophthalmopathy | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Exophthalmos | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Eye haemorrhage | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Glaucoma | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Iridocyclitis | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Iritis | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Lagophthalmos | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Macular degeneration | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Macular fibrosis | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Macular oedema | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Maculopathy | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Retinal artery occlusion | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Retinal detachment | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events2 affected8,574 at risk
- EG0016 events4 affected8,569 at risk
|
| Retinal haemorrhage | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Retinal tear | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Retinal vascular occlusion | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Retinal vein occlusion | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Tolosa-hunt syndrome | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Tractional retinal detachment | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Ulcerative keratitis | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Vision blurred | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Visual impairment | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Vitreous haemorrhage | Eye disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0017 events6 affected8,569 at risk
|
| Abdominal adhesions | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Abdominal discomfort | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Abdominal hernia | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0017 events7 affected8,569 at risk
|
| Abdominal hernia obstructive | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Abdominal incarcerated hernia | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Abdominal pain | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG00013 events13 affected8,574 at risk
- EG0019 events9 affected8,569 at risk
|
| Abdominal pain lower | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Abdominal pain upper | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0017 events5 affected8,569 at risk
|
| Acute haemorrhagic ulcerative colitis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Alcoholic pancreatitis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Anal fissure | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Anal fistula | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Ascites | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Barrett's oesophagus | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Colitis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG00111 events11 affected8,569 at risk
|
| Colitis ischaemic | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0007 events7 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Colitis microscopic | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Colitis ulcerative | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events2 affected8,569 at risk
|
| Constipation | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG00014 events13 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Diabetic gastroenteropathy | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Diabetic gastroparesis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Diarrhoea | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG00011 events10 affected8,574 at risk
- EG00111 events11 affected8,569 at risk
|
| Dieulafoy's vascular malformation | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Diverticulum | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0006 events5 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Diverticulum intestinal haemorrhagic | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Duodenal ulcer | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Duodenal ulcer haemorrhage | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events4 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Duodenal ulcer perforation | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Duodenitis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Dyspepsia | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Dysphagia | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0006 events5 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Enteritis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Enterocolitis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Enterocutaneous fistula | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Enterovesical fistula | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Epigastric discomfort | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Epiploic appendagitis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Faecaloma | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Faeces discoloured | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Food poisoning | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Gastric haemorrhage | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Gastric perforation | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gastric polyps | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Gastric stenosis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gastric ulcer | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0009 events9 affected8,574 at risk
- EG00111 events11 affected8,569 at risk
|
| Gastric ulcer haemorrhage | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Gastritis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG00015 events13 affected8,574 at risk
- EG00120 events20 affected8,569 at risk
|
| Gastritis erosive | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Gastroduodenitis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gastrointestinal angiodysplasia | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG00018 events17 affected8,574 at risk
- EG00118 events18 affected8,569 at risk
|
| Gastrointestinal inflammation | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gastrointestinal necrosis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gastrointestinal obstruction | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gastrointestinal perforation | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Gastrointestinal ulcer haemorrhage | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gastrooesophageal reflux disease | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG00110 events10 affected8,569 at risk
|
| Gingival bleeding | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Haematemesis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Haematochezia | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Haemorrhoidal haemorrhage | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Haemorrhoids | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Hernial eventration | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hiatus hernia | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Ileus | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events2 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Ileus paralytic | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Impaired gastric emptying | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Incarcerated umbilical hernia | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Inguinal hernia | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG00011 events10 affected8,574 at risk
- EG00113 events13 affected8,569 at risk
|
| Intestinal fibrosis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Intestinal haemorrhage | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Intestinal infarction | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Intestinal ischaemia | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Intestinal obstruction | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events3 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Intestinal perforation | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Intestinal polyp | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Intestinal pseudo-obstruction | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Intra-abdominal fluid collection | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Intra-abdominal haemorrhage | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Intussusception | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Jejunal perforation | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Large intestinal ulcer | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Large intestinal ulcer haemorrhage | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Large intestine perforation | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Large intestine polyp | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG00012 events12 affected8,574 at risk
- EG0019 events9 affected8,569 at risk
|
| Lower gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Lumbar hernia | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Mallory-weiss syndrome | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Melaena | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Mesenteric artery embolism | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Mesenteric artery stenosis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Mesenteric panniculitis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Mesenteric vascular insufficiency | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Nausea | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Obstruction gastric | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Obstructive pancreatitis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Odynophagia | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Oesophageal food impaction | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Oesophageal obstruction | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Oesophageal perforation | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Oesophageal ulcer | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Oesophageal varices haemorrhage | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Oesophagitis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Oesophagitis ulcerative | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Palatal oedema | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pancreatic cyst | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pancreatic duct obstruction | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pancreatic necrosis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pancreatic pseudocyst | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pancreatitis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG00012 events12 affected8,574 at risk
- EG00112 events12 affected8,569 at risk
|
| Pancreatitis acute | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG00013 events13 affected8,574 at risk
- EG00117 events15 affected8,569 at risk
|
| Pancreatitis chronic | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pancreatitis necrotising | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pancreatitis relapsing | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Pancreatolithiasis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Peptic ulcer | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Peptic ulcer haemorrhage | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Periodontal disease | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Peritoneal adhesions | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pneumoperitoneum | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Portal hypertensive gastropathy | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Proctitis | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Rectal haemorrhage | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Retroperitoneal haematoma | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Retroperitoneal haemorrhage | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Salivary gland cyst | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Small intestinal haemorrhage | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Small intestinal obstruction | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG00010 events10 affected8,574 at risk
- EG0019 events9 affected8,569 at risk
|
| Small intestinal perforation | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Small intestine ulcer | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Steatorrhoea | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Thrombosis mesenteric vessel | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Umbilical hernia | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG00110 events9 affected8,569 at risk
|
| Upper gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0018 events8 affected8,569 at risk
|
| Varices oesophageal | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0013 events2 affected8,569 at risk
|
| Vomiting | Gastrointestinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0019 events9 affected8,569 at risk
|
| Adverse drug reaction | General disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Asthenia | General disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG00110 events10 affected8,569 at risk
|
| Cardiac death | General disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Chest pain | General disorders | MedDRA 21 | Systematic Assessment | | - EG00034 events29 affected8,574 at risk
- EG00120 events20 affected8,569 at risk
|
| Complication associated with device | General disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Critical illness | General disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Death | General disorders | MedDRA 21 | Systematic Assessment | | - EG00081 events81 affected8,574 at risk
- EG00189 events89 affected8,569 at risk
|
| Dehiscence | General disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Drowning | General disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Drug intolerance | General disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Drug withdrawal syndrome | General disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Exercise tolerance decreased | General disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Gait disturbance | General disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| General physical health deterioration | General disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Generalised oedema | General disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Granuloma | General disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hernia | General disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hypothermia | General disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Impaired healing | General disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Implant site inflammation | General disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Incarcerated hernia | General disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Inflammation | General disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Malaise | General disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Medical device pain | General disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Medical device site irritation | General disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Microlithiasis | General disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Multiple organ dysfunction syndrome | General disorders | MedDRA 21 | Systematic Assessment | | - EG0009 events9 affected8,574 at risk
- EG0018 events8 affected8,569 at risk
|
| Necrobiosis | General disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Necrosis | General disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Non-cardiac chest pain | General disorders | MedDRA 21 | Systematic Assessment | | - EG000110 events93 affected8,574 at risk
- EG001120 events107 affected8,569 at risk
|
| Oedema | General disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Oedema peripheral | General disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Organ failure | General disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pacemaker syndrome | General disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pain | General disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pelvic mass | General disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Peripheral swelling | General disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Pyrexia | General disorders | MedDRA 21 | Systematic Assessment | | - EG00014 events7 affected8,574 at risk
- EG00113 events13 affected8,569 at risk
|
| Soft tissue inflammation | General disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Stent-graft endoleak | General disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Submandibular mass | General disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Sudden cardiac death | General disorders | MedDRA 21 | Systematic Assessment | | - EG00014 events14 affected8,574 at risk
- EG00116 events16 affected8,569 at risk
|
| Sudden death | General disorders | MedDRA 21 | Systematic Assessment | | - EG00021 events21 affected8,574 at risk
- EG00123 events23 affected8,569 at risk
|
| Systemic inflammatory response syndrome | General disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Vascular stent occlusion | General disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Vascular stent stenosis | General disorders | MedDRA 21 | Systematic Assessment | | - EG0008 events7 affected8,574 at risk
- EG0018 events8 affected8,569 at risk
|
| Vascular stent thrombosis | General disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Bile duct obstruction | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Bile duct stenosis | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Bile duct stone | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG00010 events9 affected8,574 at risk
- EG0018 events8 affected8,569 at risk
|
| Biliary colic | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Biliary dyskinesia | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Biliary dyspepsia | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Cholangitis | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG00012 events11 affected8,574 at risk
- EG0016 events5 affected8,569 at risk
|
| Cholangitis acute | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events4 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Cholecystitis | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG00018 events18 affected8,574 at risk
- EG00123 events22 affected8,569 at risk
|
| Cholecystitis acute | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG00025 events25 affected8,574 at risk
- EG00122 events22 affected8,569 at risk
|
| Cholecystitis chronic | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Cholelithiasis | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG00026 events26 affected8,574 at risk
- EG00140 events38 affected8,569 at risk
|
| Chronic hepatic failure | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Drug-induced liver injury | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Gallbladder cholesterolosis | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Gallbladder perforation | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gallbladder polyp | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Hepatic cirrhosis | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0008 events7 affected8,574 at risk
- EG00113 events11 affected8,569 at risk
|
| Hepatic cyst | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hepatic failure | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0014 events3 affected8,569 at risk
|
| Hepatic fibrosis | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Hepatic mass | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Hepatic steatosis | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Hepatitis | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hepatitis acute | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Hepatorenal syndrome | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hydrocholecystis | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Ischaemic hepatitis | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Jaundice | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Liver injury | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Non-alcoholic steatohepatitis | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Porcelain gallbladder | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Portal vein thrombosis | Hepatobiliary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Allergy to metals | Immune system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Allergy to vaccine | Immune system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Anaphylactic reaction | Immune system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Anaphylactic shock | Immune system disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Drug hypersensitivity | Immune system disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Hashitoxicosis | Immune system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Hypersensitivity | Immune system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Sarcoidosis | Immune system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Abdominal abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Abdominal sepsis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Abdominal wall abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Abscess limb | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0008 events8 affected8,574 at risk
- EG00110 events9 affected8,569 at risk
|
| Acquired immunodeficiency syndrome | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Acute endocarditis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Acute hepatitis b | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Acute sinusitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Amoebiasis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Anal abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Appendiceal abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0003 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Appendicitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00012 events12 affected8,574 at risk
- EG00112 events12 affected8,569 at risk
|
| Appendicitis perforated | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Arthritis bacterial | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0006 events6 affected8,574 at risk
- EG00113 events11 affected8,569 at risk
|
| Arthritis infective | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Aspergilloma | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Atypical pneumonia | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Bacteraemia | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0006 events6 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Bacterascites | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Bacterial colitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Bacterial sepsis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Bacterial tracheitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Bacteriuria | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Beta haemolytic streptococcal infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Biliary sepsis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Bone abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Brain abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Breast abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Bronchitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00016 events15 affected8,574 at risk
- EG00135 events35 affected8,569 at risk
|
| Bronchitis bacterial | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Bronchitis viral | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Burn infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Bursitis infective | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Campylobacter gastroenteritis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Cellulitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG000100 events84 affected8,574 at risk
- EG001117 events93 affected8,569 at risk
|
| Cellulitis gangrenous | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cellulitis of male external genital organ | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cellulitis orbital | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Cellulitis staphylococcal | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Central nervous system infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Chest wall abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cholecystitis infective | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0006 events6 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Chronic hepatitis c | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Chronic sinusitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Clostridial sepsis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Clostridium difficile colitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0007 events7 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Clostridium difficile infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0005 events4 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cystitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0009 events9 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Cytomegalovirus viraemia | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Dengue fever | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Device related infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Diabetic foot infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00011 events10 affected8,574 at risk
- EG00113 events13 affected8,569 at risk
|
| Diabetic gangrene | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0009 events7 affected8,574 at risk
- EG00111 events11 affected8,569 at risk
|
| Diarrhoea infectious | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Diverticulitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00024 events20 affected8,574 at risk
- EG00122 events20 affected8,569 at risk
|
| Diverticulitis intestinal haemorrhagic | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Empyema | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Encephalitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Encephalomyelitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Endocarditis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Endocarditis bacterial | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Endocarditis enterococcal | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Endocarditis staphylococcal | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Endometritis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Enteritis infectious | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Enterococcal bacteraemia | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Enterococcal sepsis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Epididymitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Epiglottitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Erysipelas | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00012 events11 affected8,574 at risk
- EG00113 events13 affected8,569 at risk
|
| Escherichia bacteraemia | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Escherichia sepsis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Escherichia urinary tract infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| External ear cellulitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Extradural abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0014 events3 affected8,569 at risk
|
| Fungal infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gangrene | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00023 events22 affected8,574 at risk
- EG00140 events30 affected8,569 at risk
|
| Gas gangrene | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gastric infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gastroenteritis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00027 events26 affected8,574 at risk
- EG00127 events27 affected8,569 at risk
|
| Gastroenteritis norovirus | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Gastroenteritis rotavirus | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gastroenteritis salmonella | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Gastroenteritis viral | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Giardiasis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Groin abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| H1n1 influenza | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hiv infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hiv-associated neurocognitive disorder | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Haematoma infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Helicobacter infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Hepatitis a | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hepatitis b | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Hepatitis e | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hepatitis viral | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Herpes zoster | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Human anaplasmosis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Implant site infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Infected skin ulcer | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Infectious colitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Infective exacerbation of chronic obstructive airways disease | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0004 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Infective gastroduodenitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Influenza | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00017 events17 affected8,574 at risk
- EG00115 events15 affected8,569 at risk
|
| Intervertebral discitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Klebsiella bacteraemia | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Klebsiella sepsis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Legionella infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Liver abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Localised infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00016 events16 affected8,574 at risk
- EG00111 events10 affected8,569 at risk
|
| Lower respiratory tract infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00011 events9 affected8,574 at risk
- EG00110 events10 affected8,569 at risk
|
| Lung abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Lung infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Lyme disease | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Malaria | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Mastitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Mastoiditis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Mediastinitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Medical device site abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Medical device site infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Medical device site joint infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Meningitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Meningitis aseptic | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Meningitis pneumococcal | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Meningitis viral | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Mucormycosis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Muscle abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Necrotising fasciitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Neurosyphilis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Neutropenic sepsis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Oesophageal candidiasis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Onychomycosis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Oral candidiasis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Orchitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Oropharyngeal candidiasis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Osteomyelitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00035 events26 affected8,574 at risk
- EG00146 events39 affected8,569 at risk
|
| Osteomyelitis acute | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Osteomyelitis chronic | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Otitis externa | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Otitis media | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Otitis media chronic | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pancreatic abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Parainfluenzae virus infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Parotitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Pelvic abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0003 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pelvic inflammatory disease | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Perineal abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Perinephric abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Periodontitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Peritonitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Peritonitis bacterial | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Peritonsillar abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pharyngitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Pleurisy viral | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pneumococcal infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pneumococcal sepsis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pneumonia | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG000212 events194 affected8,574 at risk
- EG001246 events219 affected8,569 at risk
|
| Pneumonia bacterial | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Pneumonia pneumococcal | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pneumonia respiratory syncytial viral | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pneumonia staphylococcal | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pneumonia streptococcal | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pneumonia viral | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Post procedural cellulitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Post procedural infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0009 events9 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Postoperative abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Postoperative wound infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00011 events11 affected8,574 at risk
- EG00113 events13 affected8,569 at risk
|
| Prostatic abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pulmonary sepsis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pulmonary tuberculosis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Pyelitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pyelonephritis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00014 events14 affected8,574 at risk
- EG00115 events14 affected8,569 at risk
|
| Pyelonephritis acute | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00010 events10 affected8,574 at risk
- EG00115 events15 affected8,569 at risk
|
| Pyelonephritis chronic | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Rectal abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Renal abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Respiratory syncytial virus bronchiolitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Respiratory syncytial virus bronchitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Respiratory syncytial virus infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Respiratory tract infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0017 events5 affected8,569 at risk
|
| Retroperitoneal abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Rhinitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Rickettsiosis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Rotavirus infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Salmonella bacteraemia | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Scrotal abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Scrub typhus | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Sepsis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00084 events77 affected8,574 at risk
- EG00171 events70 affected8,569 at risk
|
| Sepsis syndrome | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Septic arthritis staphylococcal | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Septic shock | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00022 events21 affected8,574 at risk
- EG00127 events24 affected8,569 at risk
|
| Sinusitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Sinusitis fungal | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Skin bacterial infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Skin infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Soft tissue infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Splenic abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Staphylococcal abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Staphylococcal bacteraemia | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Staphylococcal infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Staphylococcal sepsis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Streptococcal abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Streptococcal bacteraemia | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Streptococcal sepsis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Tick-borne fever | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Tonsillitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Tooth abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Tooth infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Tracheitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Tracheobronchitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Tuberculosis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Upper respiratory tract infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Urinary tract infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00053 events49 affected8,574 at risk
- EG00171 events67 affected8,569 at risk
|
| Urinary tract infection bacterial | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Urinary tract infection enterococcal | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Urosepsis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00023 events22 affected8,574 at risk
- EG00126 events25 affected8,569 at risk
|
| Vestibular neuronitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Viraemia | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Viral infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0018 events7 affected8,569 at risk
|
| Viral myocarditis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Viral sinusitis | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Viral upper respiratory tract infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| West nile viral infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Wound abscess | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Wound infection | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG00012 events11 affected8,574 at risk
- EG00111 events10 affected8,569 at risk
|
| Wound infection pseudomonas | Infections and infestations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Abdominal injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Abdominal wall wound | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Abdominal wound dehiscence | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Accidental overdose | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Accidental poisoning | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Acetabulum fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Alcohol poisoning | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Allergic transfusion reaction | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Anaemia postoperative | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Anastomotic leak | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Anastomotic ulcer | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Ankle fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG00019 events19 affected8,574 at risk
- EG00114 events14 affected8,569 at risk
|
| Arterial bypass occlusion | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0004 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Arterial injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Arterial restenosis | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Avulsion fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Back injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Bone contusion | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Brain contusion | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Burns second degree | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cardiac procedure complication | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cardiac valve replacement complication | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Carotid artery restenosis | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Cartilage injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cataract operation complication | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Cement embolism | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cervical vertebral fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Chest crushing | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Chest injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Clavicle fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Complications of transplanted liver | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Compression fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Concussion | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0017 events7 affected8,569 at risk
|
| Confusion postoperative | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Contusion | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Coronary artery restenosis | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Coronary bypass stenosis | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Costal cartilage fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Craniocerebral injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Cystitis radiation | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Exposure to toxic agent | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Extradural haematoma | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Eyelid injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Facial bones fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG00010 events10 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Fall | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG00014 events14 affected8,574 at risk
- EG00120 events20 affected8,569 at risk
|
| Femoral neck fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0019 events9 affected8,569 at risk
|
| Femur fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG00016 events16 affected8,574 at risk
- EG00118 events18 affected8,569 at risk
|
| Fibula fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Foot fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Foreign body in gastrointestinal tract | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Foreign body in respiratory tract | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Fracture displacement | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Fractured sacrum | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gun shot wound | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Haematuria traumatic | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hand fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Head injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0005 events4 affected8,574 at risk
- EG0018 events8 affected8,569 at risk
|
| Heat stroke | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Hip fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG00013 events13 affected8,574 at risk
- EG00116 events15 affected8,569 at risk
|
| Humerus fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG00012 events11 affected8,574 at risk
- EG00120 events20 affected8,569 at risk
|
| Ilium fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events1 affected8,569 at risk
|
| Incisional hernia | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0006 events6 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Intentional overdose | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Jaw fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Joint dislocation | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Joint injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Laceration | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Ligament rupture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Ligament sprain | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0004 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Limb crushing injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Limb fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Limb injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0008 events7 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Limb traumatic amputation | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Lisfranc fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Lower limb fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0019 events9 affected8,569 at risk
|
| Lumbar vertebral fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Meniscus injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0006 events6 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Multiple fractures | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Multiple injuries | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Muscle rupture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Muscle strain | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Nerve injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events1 affected8,569 at risk
|
| Ocular procedural complication | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Overdose | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Patella fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pelvic fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Periorbital haematoma | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Peripheral artery restenosis | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0015 events3 affected8,569 at risk
|
| Periprocedural myocardial infarction | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Periprosthetic fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pneumoconiosis | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pneumothorax traumatic | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Post concussion syndrome | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Post laminectomy syndrome | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Post procedural complication | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0008 events8 affected8,574 at risk
- EG00114 events14 affected8,569 at risk
|
| Post procedural constipation | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Post procedural discharge | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Post procedural haematoma | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Post procedural haematuria | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Post procedural haemorrhage | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG00012 events11 affected8,574 at risk
- EG0015 events4 affected8,569 at risk
|
| Post procedural inflammation | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Post procedural myocardial infarction | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Postoperative delirium | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Postoperative ileus | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Postoperative respiratory failure | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Postoperative thoracic procedure complication | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Postoperative thrombosis | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Postoperative wound complication | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Procedural complication | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Procedural haemorrhage | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Procedural pain | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Procedural pneumothorax | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Procedural shock | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pubis fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Radiation oesophagitis | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Radius fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0008 events7 affected8,574 at risk
- EG00110 events10 affected8,569 at risk
|
| Rectal laceration postoperative | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Rib fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG00013 events12 affected8,574 at risk
- EG00117 events15 affected8,569 at risk
|
| Road traffic accident | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0008 events8 affected8,574 at risk
- EG0017 events7 affected8,569 at risk
|
| Sedation complication | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Seroma | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Skin abrasion | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Skin injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Skin wound | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Skull fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Skull fractured base | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Soft tissue injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Spinal column injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Spinal compression fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG00012 events12 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Spinal fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Splenic injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Splenic rupture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Stab wound | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Sternal fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Stoma site haemorrhage | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Subarachnoid haemorrhage | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0006 events6 affected8,574 at risk
- EG0019 events9 affected8,569 at risk
|
| Subcutaneous haematoma | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Subdural haematoma | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0009 events8 affected8,574 at risk
- EG00113 events11 affected8,569 at risk
|
| Subdural haemorrhage | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Tendon injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Tendon rupture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0018 events8 affected8,569 at risk
|
| Thermal burn | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Thoracic vertebral fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Tibia fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG00012 events12 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Tongue injury | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Toxicity to various agents | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Transfusion reaction | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Transplant dysfunction | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Traumatic arthritis | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Traumatic fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Traumatic haemothorax | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Traumatic intracranial haemorrhage | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Ulna fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Upper limb fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0008 events8 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Vascular graft occlusion | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Vascular graft restenosis | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Vascular graft thrombosis | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Vascular pseudoaneurysm | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Wound | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Wound dehiscence | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Wound haematoma | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Wound necrosis | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Wrist fracture | Injury, poisoning and procedural complications | MedDRA 21 | Systematic Assessment | | - EG0006 events6 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Anticoagulation drug level below therapeutic | Investigations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Blood creatine phosphokinase increased | Investigations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Blood creatinine increased | Investigations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Blood glucose abnormal | Investigations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Blood glucose increased | Investigations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Blood pressure decreased | Investigations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Blood pressure increased | Investigations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Brain natriuretic peptide increased | Investigations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Catheterisation cardiac | Investigations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Electrocardiogram qt prolonged | Investigations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Electrocardiogram st segment elevation | Investigations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| General physical condition abnormal | Investigations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Glomerular filtration rate decreased | Investigations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hepatic enzyme increased | Investigations | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Hepatitis c antibody positive | Investigations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events1 affected8,569 at risk
|
| International normalised ratio increased | Investigations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Liver function test increased | Investigations | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Transaminases increased | Investigations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Troponin i increased | Investigations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Troponin t increased | Investigations | MedDRA 21 | Systematic Assessment | | - EG0004 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Troponin increased | Investigations | MedDRA 21 | Systematic Assessment | | - EG00012 events11 affected8,574 at risk
- EG0018 events7 affected8,569 at risk
|
| Urine cytology abnormal | Investigations | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Weight decreased | Investigations | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Adult failure to thrive | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Alcoholic ketoacidosis | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Decreased appetite | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Dehydration | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG00021 events20 affected8,574 at risk
- EG00119 events19 affected8,569 at risk
|
| Diabetes mellitus | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0006 events5 affected8,574 at risk
- EG00113 events13 affected8,569 at risk
|
| Diabetes mellitus inadequate control | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG00014 events14 affected8,574 at risk
- EG00134 events29 affected8,569 at risk
|
| Diabetes with hyperosmolarity | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Diabetic complication | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Diabetic ketoacidosis | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG00029 events27 affected8,574 at risk
- EG00127 events23 affected8,569 at risk
|
| Diabetic ketosis | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Diabetic metabolic decompensation | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG00023 events17 affected8,574 at risk
- EG00135 events27 affected8,569 at risk
|
| Electrolyte imbalance | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Euglycaemic diabetic ketoacidosis | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Failure to thrive | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Fluid overload | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Fluid retention | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gout | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0017 events6 affected8,569 at risk
|
| Hypercalcaemia | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hyperglycaemia | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG00049 events37 affected8,574 at risk
- EG00156 events55 affected8,569 at risk
|
| Hyperglycaemic hyperosmolar nonketotic syndrome | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Hyperkalaemia | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0006 events6 affected8,574 at risk
- EG0017 events6 affected8,569 at risk
|
| Hyperlipidaemia | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hypernatraemia | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Hypertriglyceridaemia | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hyperuricaemia | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hypocalcaemia | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Hypoglycaemia | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG00086 events69 affected8,574 at risk
- EG001101 events86 affected8,569 at risk
|
| Hypokalaemia | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Hypomagnesaemia | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hyponatraemia | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG00010 events9 affected8,574 at risk
- EG0019 events9 affected8,569 at risk
|
| Hypovolaemia | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG00014 events14 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Ketoacidosis | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0008 events7 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Ketosis | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Lactic acidosis | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Latent autoimmune diabetes in adults | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Lipomatosis | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Malnutrition | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Metabolic acidosis | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Obesity | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0018 events8 affected8,569 at risk
|
| Type 1 diabetes mellitus | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Type 2 diabetes mellitus | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0007 events7 affected8,574 at risk
- EG0017 events7 affected8,569 at risk
|
| Vitamin d deficiency | Metabolism and nutrition disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Arthralgia | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0007 events7 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Arthritis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG00014 events14 affected8,574 at risk
- EG0019 events9 affected8,569 at risk
|
| Arthritis reactive | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Arthropathy | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Articular calcification | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0006 events5 affected8,574 at risk
- EG0019 events9 affected8,569 at risk
|
| Bursitis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Cervical spinal stenosis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0006 events6 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Chondromalacia | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Chondropathy | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Compartment syndrome | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Costochondritis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events3 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Diastasis recti abdominis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Dupuytren's contracture | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Extraskeletal ossification | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Facet joint syndrome | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Fasciitis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Flank pain | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Foot deformity | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Fracture malunion | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Fracture nonunion | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Gouty arthritis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Haemarthrosis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Immunoglobulin g4 related disease | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Intervertebral disc compression | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Intervertebral disc degeneration | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Intervertebral disc disorder | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Intervertebral disc displacement | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Intervertebral disc protrusion | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG00025 events24 affected8,574 at risk
- EG00118 events17 affected8,569 at risk
|
| Jaw cyst | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Joint ankylosis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Joint contracture | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Ligament calcification | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Lumbar spinal stenosis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG00015 events14 affected8,574 at risk
- EG00118 events18 affected8,569 at risk
|
| Meniscal degeneration | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Mobility decreased | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Muscle fibrosis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Muscle haemorrhage | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Muscle spasms | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Muscular weakness | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Musculoskeletal chest pain | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG00012 events12 affected8,574 at risk
- EG00125 events24 affected8,569 at risk
|
| Musculoskeletal pain | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Myalgia | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Myositis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Neck pain | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Neuropathic arthropathy | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Osteitis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events3 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG000114 events103 affected8,574 at risk
- EG001102 events92 affected8,569 at risk
|
| Osteochondrosis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Osteolysis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Osteonecrosis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Osteoporosis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Osteoporotic fracture | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pain in extremity | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Pain in jaw | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Patellofemoral pain syndrome | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pathological fracture | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Periarthritis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Polyarthritis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Polymyalgia rheumatica | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Pseudarthrosis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Psoriatic arthropathy | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Rhabdomyolysis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0017 events7 affected8,569 at risk
|
| Rheumatoid arthritis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0008 events7 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Rotator cuff syndrome | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG00116 events16 affected8,569 at risk
|
| Sjogren's syndrome | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Spinal column stenosis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG00011 events11 affected8,574 at risk
- EG00113 events12 affected8,569 at risk
|
| Spinal ligament ossification | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Spinal osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0009 events9 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Spinal pain | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events4 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Spondylitis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Spondylolisthesis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0016 events5 affected8,569 at risk
|
| Synovial cyst | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Tendonitis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Tenosynovitis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Tenosynovitis stenosans | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Trigger finger | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Vertebral foraminal stenosis | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Vertebral lesion | Musculoskeletal and connective tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Acral lentiginous melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Acute myeloid leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0013 events2 affected8,569 at risk
|
| Acute myelomonocytic leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Adenocarcinoma gastric | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Adenocarcinoma of appendix | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Adenocarcinoma of colon | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG00020 events20 affected8,574 at risk
- EG00118 events18 affected8,569 at risk
|
| Adenocarcinoma pancreas | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Adenoid cystic carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Adenoma benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Adrenal adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Adrenal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Adrenocortical carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Anal squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Anaplastic astrocytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Anaplastic large-cell lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| B-cell lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Basal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG00042 events34 affected8,574 at risk
- EG00137 events27 affected8,569 at risk
|
| Basosquamous carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Benign breast neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Benign ear neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Benign gastric neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Benign gastrointestinal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Benign hepatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Benign laryngeal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Benign lung neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Benign lymph node neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Benign neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Benign neoplasm of adrenal gland | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Benign neoplasm of bladder | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Benign neoplasm of spinal cord | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Benign neoplasm of thyroid gland | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Benign ovarian tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Benign pancreatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Benign renal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Benign salivary gland neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Benign soft tissue neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Bladder cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG00012 events12 affected8,574 at risk
- EG00125 events25 affected8,569 at risk
|
| Bladder cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Bladder cancer stage 0, with cancer in situ | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Bladder cancer stage ii | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Bladder neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Bladder papilloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Bladder transitional cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0018 events8 affected8,569 at risk
|
| Bladder transitional cell carcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Bone cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Bone cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Bone neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Bowen's disease | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0003 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Brain neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Brain neoplasm benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Brain neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Breast cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Breast cancer female | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG00020 events19 affected8,574 at risk
- EG00122 events20 affected8,569 at risk
|
| Breast cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0015 events4 affected8,569 at risk
|
| Breast neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Bronchial carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Cancer pain | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Carcinoid tumour of the duodenum | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Carcinoid tumour of the small bowel | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Central nervous system lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Cervix carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Cholangiocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0017 events7 affected8,569 at risk
|
| Chondromatosis | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Chondrosarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Chronic leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Chronic lymphocytic leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0007 events7 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Chronic myeloid leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Clear cell renal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Colon adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0008 events8 affected8,574 at risk
- EG0017 events7 affected8,569 at risk
|
| Colon cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG00017 events16 affected8,574 at risk
- EG00116 events16 affected8,569 at risk
|
| Colon cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Colon neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Colorectal adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Colorectal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Colorectal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Dermatofibrosarcoma protuberans | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Diffuse large b-cell lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Diffuse large b-cell lymphoma stage i | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Ductal adenocarcinoma of pancreas | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Endometrial adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0018 events7 affected8,569 at risk
|
| Endometrial cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Endometrial cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Endometrial cancer stage i | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Fallopian tube cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Fibroadenoma of breast | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Follicular thyroid cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Gallbladder adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Gallbladder cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gallbladder neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gastric adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Gastric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0018 events8 affected8,569 at risk
|
| Gastric cancer stage 0 | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gastric cancer stage iii | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Gastrointestinal adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Gastrointestinal carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Gastrointestinal stromal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Gastrointestinal stromal tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Gastrointestinal tract adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Gingival cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Glioblastoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Glioblastoma multiforme | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Glottis carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Haemangioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Haemangiopericytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hairy cell leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Hepatic cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Hepatic cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hepatocellular carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0009 events8 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Hodgkin's disease | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hypopharyngeal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Infected neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Intestinal adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Intraductal proliferative breast lesion | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Invasive breast carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Invasive ductal breast carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0009 events9 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Invasive lobular breast carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Juvenile melanoma benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Keratoacanthoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Large intestine benign neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Laryngeal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Laryngeal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Laryngeal squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Lentigo maligna | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Lipoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Liposarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Lung adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0017 events6 affected8,569 at risk
|
| Lung adenocarcinoma stage iii | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG00012 events11 affected8,574 at risk
- EG00114 events14 affected8,569 at risk
|
| Lung carcinoma cell type unspecified stage 0 | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Lung carcinoma cell type unspecified stage iv | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Lung neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Lung neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG00013 events12 affected8,574 at risk
- EG00121 events21 affected8,569 at risk
|
| Lung squamous cell carcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Lymphocytic leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Malignant anorectal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Malignant melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG00017 events13 affected8,574 at risk
- EG00112 events12 affected8,569 at risk
|
| Malignant melanoma in situ | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0007 events6 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Malignant neoplasm of ampulla of vater | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Malignant neoplasm of pleura metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Malignant neoplasm of renal pelvis | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Malignant neoplasm of unknown primary site | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Malignant peritoneal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Malignant pleural effusion | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Melanocytic naevus | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Melanoma recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Meningioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Meningioma benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Mesothelioma malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Metastases to adrenals | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Metastases to bone | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Metastases to central nervous system | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Metastases to lung | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Metastases to lymph nodes | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Metastases to peritoneum | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Metastases to rectum | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Metastases to spinal cord | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Metastases to spine | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Metastatic bronchial carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Metastatic carcinoma of the bladder | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Metastatic gastric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Metastatic malignant melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0005 events3 affected8,574 at risk
- EG0017 events5 affected8,569 at risk
|
| Metastatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Metastatic renal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Metastatic squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Monoclonal gammopathy | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Myelodysplastic syndrome | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Myeloproliferative neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Nasopharyngeal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Neoplasm prostate | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Neoplasm skin | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Neuroendocrine tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Neuroendocrine tumour of the lung | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Neuroendocrine tumour of the lung metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Non-hodgkin's lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Non-hodgkin's lymphoma stage iv | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Non-small cell lung cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Non-small cell lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Non-small cell lung cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Non-small cell lung cancer stage iv | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Ocular neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Oesophageal adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Oesophageal carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Oesophageal squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Oral neoplasm benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Oropharyngeal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Osteoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Ovarian adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Ovarian cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Ovarian cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Ovarian epithelial cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Ovarian neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pancreatic carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0009 events9 affected8,574 at risk
- EG0018 events8 affected8,569 at risk
|
| Pancreatic carcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0009 events8 affected8,574 at risk
- EG00110 events9 affected8,569 at risk
|
| Pancreatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pancreatic neuroendocrine tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pancreatoblastoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Papillary cystadenoma lymphomatosum | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Papillary renal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Papillary serous endometrial carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Papillary thyroid cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Papillary tumour of renal pelvis | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Parathyroid tumour benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Pelvic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Penile squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Peritoneal carcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Phaeochromocytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pharyngeal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pituitary tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pituitary tumour benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Plasma cell leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Plasma cell myeloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Pleomorphic adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Prostate cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG00070 events69 affected8,574 at risk
- EG00155 events55 affected8,569 at risk
|
| Prostate cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0006 events6 affected8,574 at risk
- EG0017 events7 affected8,569 at risk
|
| Prostate cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Prostate cancer stage iv | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Prostatic adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Rectal adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Rectal adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Rectal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Rectal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0003 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Renal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG00010 events10 affected8,574 at risk
- EG0018 events7 affected8,569 at risk
|
| Renal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG00010 events10 affected8,574 at risk
- EG0018 events8 affected8,569 at risk
|
| Renal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0006 events6 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Retro-orbital neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Salivary gland cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Salivary gland neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Sebaceous carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Seborrhoeic keratosis | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Signet-ring cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Small cell lung cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Small cell lung cancer extensive stage | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Small cell lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Small intestine adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Soft tissue sarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Spinal cord neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG00012 events8 affected8,574 at risk
- EG00110 events10 affected8,569 at risk
|
| Squamous cell carcinoma of lung | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Squamous cell carcinoma of skin | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG00112 events9 affected8,569 at risk
|
| Squamous cell carcinoma of the oral cavity | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Squamous cell carcinoma of the tongue | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| T-cell lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Throat cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Thyroid adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Thyroid cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Thyroid cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Thyroid neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Tongue neoplasm malignant stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Tonsil cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Transitional cell cancer of the renal pelvis and ureter | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Transitional cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG00011 events11 affected8,574 at risk
- EG00114 events12 affected8,569 at risk
|
| Transitional cell carcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Transitional cell carcinoma recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Tumour obstruction | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Uterine cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Uterine leiomyoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Vaginal cancer stage 0 | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0003 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Vocal cord neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Vulval cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0012 events1 affected8,569 at risk
|
| Vulval cancer stage 0 | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Amnesia | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Amyotrophic lateral sclerosis | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Aphasia | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events1 affected8,569 at risk
|
| Arachnoid cyst | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Ataxia | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Autonomic failure syndrome | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Balance disorder | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Basal ganglia infarction | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Basilar artery perforation | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Brain injury | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Brain oedema | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Brain stem haemorrhage | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Brain stem infarction | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0008 events6 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Brain stem stroke | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Burning sensation | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Carotid arteriosclerosis | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Carotid artery insufficiency | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Carotid artery occlusion | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Carotid artery stenosis | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG00027 events27 affected8,574 at risk
- EG00122 events21 affected8,569 at risk
|
| Carotid sinus syndrome | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Carpal tunnel syndrome | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Cerebellar ataxia | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Cerebellar haemorrhage | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Cerebellar infarction | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Cerebellar stroke | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cerebral artery embolism | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Cerebral artery occlusion | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cerebral atrophy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Cerebral haematoma | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cerebral haemorrhage | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0007 events7 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Cerebral infarction | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG00027 events24 affected8,574 at risk
- EG00133 events32 affected8,569 at risk
|
| Cerebral ischaemia | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0006 events6 affected8,574 at risk
- EG00110 events9 affected8,569 at risk
|
| Cerebrovascular accident | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG000112 events102 affected8,574 at risk
- EG00194 events88 affected8,569 at risk
|
| Cerebrovascular disorder | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cerebrovascular insufficiency | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Cervical cord compression | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Cervical radiculopathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events3 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Cervicobrachial syndrome | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cluster headache | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Cognitive disorder | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Coma | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cranial nerve palsies multiple | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Dementia | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Dementia alzheimer's type | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Dementia with lewy bodies | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Demyelinating polyneuropathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Diabetic autonomic neuropathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Diabetic coma | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Diabetic hyperosmolar coma | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Diabetic neuropathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0015 events4 affected8,569 at risk
|
| Dizziness | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG00014 events14 affected8,574 at risk
- EG0019 events9 affected8,569 at risk
|
| Dizziness postural | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Dysarthria | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Dystonic tremor | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Embolic stroke | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Encephalopathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0018 events8 affected8,569 at risk
|
| Epilepsy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Essential tremor | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Facial paralysis | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0018 events8 affected8,569 at risk
|
| Facial paresis | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Focal dyscognitive seizures | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Generalised tonic-clonic seizure | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0013 events2 affected8,569 at risk
|
| Guillain-barre syndrome | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Haemorrhage intracranial | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Haemorrhagic cerebral infarction | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Haemorrhagic stroke | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG00111 events11 affected8,569 at risk
|
| Haemorrhagic transformation stroke | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Headache | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Hemianopia homonymous | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hemiparesis | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hepatic encephalopathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events3 affected8,574 at risk
- EG0015 events4 affected8,569 at risk
|
| Hydrocephalus | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Hypertensive encephalopathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hypoaesthesia | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Hypoglycaemic coma | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Hypoglycaemic encephalopathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hypoglycaemic unconsciousness | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hypokinesia | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Hypoxic-ischaemic encephalopathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Iiird nerve paralysis | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Intensive care unit acquired weakness | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Intracranial aneurysm | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Intraventricular haemorrhage | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Ischaemic cerebral infarction | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Ischaemic neuropathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Ischaemic stroke | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG000105 events97 affected8,574 at risk
- EG00199 events90 affected8,569 at risk
|
| Lacunar infarction | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0009 events8 affected8,574 at risk
- EG00114 events14 affected8,569 at risk
|
| Lacunar stroke | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Lateral medullary syndrome | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Loss of consciousness | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Lumbar radiculopathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Lumbosacral radiculopathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Medication overuse headache | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Memory impairment | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Metabolic encephalopathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Migraine | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Multiple system atrophy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Muscle contractions involuntary | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Myasthenia gravis | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Myelopathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Nerve compression | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Nervous system disorder | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Neuralgia | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Neurodegenerative disorder | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Neurological symptom | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Neuropathy peripheral | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Normal pressure hydrocephalus | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Occipital neuralgia | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Paraesthesia | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Paraparesis | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Parkinson's disease | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0016 events3 affected8,569 at risk
|
| Partial seizures | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Peroneal nerve palsy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Polyneuropathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Post herpetic neuralgia | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Postictal paralysis | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Presyncope | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Quadriplegia | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Radicular pain | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Radicular syndrome | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Radiculopathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Ruptured cerebral aneurysm | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Sciatica | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0017 events7 affected8,569 at risk
|
| Seizure | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0006 events5 affected8,574 at risk
- EG00110 events10 affected8,569 at risk
|
| Simple partial seizures | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Somnolence | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Spinal claudication | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Spondylitic myelopathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Status epilepticus | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Stiff person syndrome | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Stroke in evolution | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Subdural hygroma | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Syncope | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG00038 events37 affected8,574 at risk
- EG00144 events41 affected8,569 at risk
|
| Tension headache | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Thalamic infarction | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Thoracic outlet syndrome | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Thrombotic cerebral infarction | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Thrombotic stroke | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Toxic encephalopathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Toxic neuropathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Transient ischaemic attack | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG00076 events68 affected8,574 at risk
- EG00159 events54 affected8,569 at risk
|
| Tremor | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Vith nerve paralysis | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Vith nerve paresis | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Vascular dementia | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Vascular encephalopathy | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Vertebral artery stenosis | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Vertebrobasilar insufficiency | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Vertigo cns origin | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Vocal cord paralysis | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Wernicke-korsakoff syndrome | Nervous system disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Device breakage | Product Issues | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Device dislocation | Product Issues | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Device failure | Product Issues | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Device lead damage | Product Issues | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Device malfunction | Product Issues | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0012 events1 affected8,569 at risk
|
| Device occlusion | Product Issues | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Stent malfunction | Product Issues | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Acute psychosis | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Adjustment disorder | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Agitation | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Alcohol withdrawal syndrome | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Anxiety | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Anxiety disorder | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Completed suicide | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Confusional state | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG00112 events12 affected8,569 at risk
|
| Conversion disorder | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Delirium | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Depressed mood | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Depression | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG00115 events13 affected8,569 at risk
|
| Drug abuse | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Hallucination | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hypomania | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Major depression | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Mental status changes | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0017 events7 affected8,569 at risk
|
| Mood disorder due to a general medical condition | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Panic attack | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Post-traumatic stress disorder | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Restlessness | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Schizoaffective disorder | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events1 affected8,569 at risk
|
| Schizoaffective disorder depressive type | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Schizophrenia | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Sleep disorder | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Stress | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Suicidal ideation | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Suicide attempt | Psychiatric disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events2 affected8,569 at risk
|
| Acute kidney injury | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG00096 events94 affected8,574 at risk
- EG001152 events127 affected8,569 at risk
|
| Azotaemia | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Bladder disorder | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Bladder mass | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Bladder outlet obstruction | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Bladder perforation | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Bladder prolapse | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Calculus bladder | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Calculus urethral | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Calculus urinary | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Chronic kidney disease | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG00010 events9 affected8,574 at risk
- EG00117 events13 affected8,569 at risk
|
| Cystitis glandularis | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cystitis haemorrhagic | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cystitis noninfective | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Cystitis ulcerative | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Diabetic nephropathy | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0013 events2 affected8,569 at risk
|
| Dysuria | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| End stage renal disease | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0018 events7 affected8,569 at risk
|
| Glomerulonephritis | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Haematuria | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG00119 events16 affected8,569 at risk
|
| Hydronephrosis | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Ketonuria | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Lower urinary tract symptoms | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Myeloma cast nephropathy | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Nephrolithiasis | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG00016 events14 affected8,574 at risk
- EG00118 events18 affected8,569 at risk
|
| Nephrotic syndrome | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Oedematous kidney | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pelvi-ureteric obstruction | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pollakiuria | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Proteinuria | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Renal artery stenosis | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Renal colic | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Renal cyst | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Renal cyst ruptured | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Renal disorder | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Renal failure | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG00011 events10 affected8,574 at risk
- EG00117 events17 affected8,569 at risk
|
| Renal haematoma | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Renal impairment | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG00112 events12 affected8,569 at risk
|
| Renal infarct | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Renal injury | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Renal tubular acidosis | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Renal tubular necrosis | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Stress urinary incontinence | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Ureteric stenosis | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Ureterolithiasis | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0007 events5 affected8,574 at risk
- EG00121 events17 affected8,569 at risk
|
| Urethral meatus stenosis | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Urethral obstruction | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Urethral stenosis | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0016 events5 affected8,569 at risk
|
| Urinary bladder haemorrhage | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Urinary bladder polyp | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Urinary incontinence | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Urinary retention | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0008 events8 affected8,574 at risk
- EG00110 events10 affected8,569 at risk
|
| Urinary tract obstruction | Renal and urinary disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Acquired hydrocele | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Acquired phimosis | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG00011 events11 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Balanoposthitis | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Benign prostatic hyperplasia | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG00030 events28 affected8,574 at risk
- EG00131 events31 affected8,569 at risk
|
| Breast mass | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Breast pain | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Cervical dysplasia | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Colpocele | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Cystocele | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Endometrial hyperplasia | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Endometrial hypertrophy | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Erectile dysfunction | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Female genital tract fistula | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Gynaecomastia | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hydrosalpinx | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Ovarian cyst | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pelvic haemorrhage | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pelvic prolapse | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Penile necrosis | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Peyronie's disease | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Postmenopausal haemorrhage | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Prostatic disorder | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Prostatitis | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0019 events8 affected8,569 at risk
|
| Prostatomegaly | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Rectocele | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Testicular cyst | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Uterine polyp | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Uterine prolapse | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0006 events6 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Uterovaginal prolapse | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Vaginal dysplasia | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Vaginal prolapse | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Varicocele | Reproductive system and breast disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Acute pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0018 events8 affected8,569 at risk
|
| Acute respiratory distress syndrome | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Acute respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG00041 events37 affected8,574 at risk
- EG00150 events43 affected8,569 at risk
|
| Alveolitis allergic | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Apnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Aspiration | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Asthma | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0006 events6 affected8,574 at risk
- EG00121 events18 affected8,569 at risk
|
| Asthma-chronic obstructive pulmonary disease overlap syndrome | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Asthmatic crisis | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Atelectasis | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Bronchial hyperreactivity | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Bronchiectasis | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Bronchitis chronic | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Bronchospasm | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG00081 events54 affected8,574 at risk
- EG00190 events54 affected8,569 at risk
|
| Chronic respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG00122 events21 affected8,569 at risk
|
| Dyspnoea exertional | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Emphysema | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Epistaxis | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Haemoptysis | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Haemothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Hydrothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Hypoxia | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Idiopathic pulmonary fibrosis | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Interstitial lung disease | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Lung disorder | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Lung infiltration | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Nasal polyps | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Nasal septum deviation | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Obstructive airways disorder | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Paraneoplastic pleural effusion | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pickwickian syndrome | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pleural effusion | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0007 events6 affected8,574 at risk
- EG00114 events13 affected8,569 at risk
|
| Pleural thickening | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pleurisy | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Pleuritic pain | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pneumonia aspiration | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG00019 events18 affected8,574 at risk
- EG00110 events10 affected8,569 at risk
|
| Pneumonitis | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Pneumothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0006 events6 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Pulmonary amyloidosis | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pulmonary arterial hypertension | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0013 events2 affected8,569 at risk
|
| Pulmonary congestion | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG00026 events26 affected8,574 at risk
- EG00127 events27 affected8,569 at risk
|
| Pulmonary fibrosis | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pulmonary haemorrhage | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pulmonary hypertension | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG00119 events4 affected8,569 at risk
|
| Pulmonary infarction | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Pulmonary mass | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events2 affected8,574 at risk
- EG00111 events11 affected8,569 at risk
|
| Pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG00116 events15 affected8,569 at risk
|
| Pulmonary thrombosis | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Reflux laryngitis | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Respiratory acidosis | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Respiratory arrest | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Respiratory distress | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG00030 events29 affected8,574 at risk
- EG00128 events24 affected8,569 at risk
|
| Restrictive pulmonary disease | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Rheumatoid lung | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Rhinitis hypertrophic | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Sleep apnoea syndrome | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Vocal cord leukoplakia | Respiratory, thoracic and mediastinal disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Actinic keratosis | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Angioedema | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Decubitus ulcer | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Dermal cyst | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Dermatitis contact | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Diabetic bullosis | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Diabetic foot | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG00045 events37 affected8,574 at risk
- EG00134 events29 affected8,569 at risk
|
| Diabetic ulcer | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Eczema | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Erythema multiforme | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Fixed eruption | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Henoch-schonlein purpura | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hidradenitis | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hypersensitivity vasculitis | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Ischaemic skin ulcer | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Keloid scar | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Lichen planus | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Lichen sclerosus | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Melanocytic hyperplasia | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Neuropathic ulcer | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Purpura | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Pyoderma gangrenosum | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Skin swelling | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Skin ulcer | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG00028 events24 affected8,574 at risk
- EG00126 events23 affected8,569 at risk
|
| Stasis dermatitis | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Toxic skin eruption | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Urticaria | Skin and subcutaneous tissue disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Hospitalisation | Surgical and medical procedures | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Accelerated hypertension | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Angiopathy | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Aortic aneurysm | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG00012 events12 affected8,574 at risk
- EG00111 events10 affected8,569 at risk
|
| Aortic aneurysm rupture | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Aortic dilatation | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Aortic dissection | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Aortic stenosis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG00022 events22 affected8,574 at risk
- EG00117 events17 affected8,569 at risk
|
| Arterial disorder | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Arterial insufficiency | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Arterial occlusive disease | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Arterial perforation | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Arterial thrombosis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Arteriosclerosis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events4 affected8,574 at risk
- EG0015 events5 affected8,569 at risk
|
| Arteriovenous fistula | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Arteritis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Bleeding varicose vein | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Blood pressure fluctuation | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Circulatory collapse | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Claudication of jaw muscles | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Deep vein thrombosis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG00018 events17 affected8,574 at risk
- EG00112 events12 affected8,569 at risk
|
| Diabetic vascular disorder | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Dry gangrene | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0004 events3 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Embolism | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Essential hypertension | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Extremity necrosis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0007 events7 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Femoral artery aneurysm | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Femoral artery embolism | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Haematoma | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0016 events6 affected8,569 at risk
|
| Haemorrhagic vasculitis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Hypertension | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG00028 events27 affected8,574 at risk
- EG00131 events27 affected8,569 at risk
|
| Hypertensive crisis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG00021 events14 affected8,574 at risk
- EG00128 events24 affected8,569 at risk
|
| Hypertensive emergency | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0017 events7 affected8,569 at risk
|
| Hypotension | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG00029 events28 affected8,574 at risk
- EG00114 events14 affected8,569 at risk
|
| Hypovolaemic shock | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Iliac artery disease | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Iliac artery embolism | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Iliac artery occlusion | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Intermittent claudication | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events5 affected8,574 at risk
- EG0013 events3 affected8,569 at risk
|
| Internal haemorrhage | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Ischaemia | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Ischaemic limb pain | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Jugular vein thrombosis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Leriche syndrome | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Lymphatic fistula | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Lymphoedema | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Malignant hypertension | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Microangiopathy | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Orthostatic hypotension | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0006 events6 affected8,574 at risk
- EG00113 events12 affected8,569 at risk
|
| Peripheral arterial occlusive disease | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG00056 events43 affected8,574 at risk
- EG00153 events49 affected8,569 at risk
|
| Peripheral artery aneurysm | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Peripheral artery dissection | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Peripheral artery haematoma | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Peripheral artery occlusion | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG00018 events14 affected8,574 at risk
- EG00120 events15 affected8,569 at risk
|
| Peripheral artery stenosis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG00036 events23 affected8,574 at risk
- EG00122 events20 affected8,569 at risk
|
| Peripheral artery thrombosis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0005 events4 affected8,574 at risk
- EG0014 events4 affected8,569 at risk
|
| Peripheral embolism | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Peripheral ischaemia | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG00032 events30 affected8,574 at risk
- EG00141 events35 affected8,569 at risk
|
| Peripheral vascular disorder | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG00046 events34 affected8,574 at risk
- EG00121 events19 affected8,569 at risk
|
| Peripheral venous disease | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Phlebitis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Raynaud's phenomenon | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Shock | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0012 events2 affected8,569 at risk
|
| Shock haemorrhagic | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Subclavian artery occlusion | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Subclavian artery stenosis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Subclavian steal syndrome | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Superior vena cava stenosis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Temporal arteritis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events1 affected8,574 at risk
- EG0013 events2 affected8,569 at risk
|
| Thromboangiitis obliterans | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0000 events0 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Thrombophlebitis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Thrombophlebitis superficial | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0002 events2 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Thrombosis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0003 events3 affected8,574 at risk
- EG0011 events1 affected8,569 at risk
|
| Varicose ulceration | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Varicose vein | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0016 events5 affected8,569 at risk
|
| Vascular occlusion | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Vasculitis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Vasospasm | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Venous thrombosis | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|
| Venous thrombosis limb | Vascular disorders | MedDRA 21 | Systematic Assessment | | - EG0001 events1 affected8,574 at risk
- EG0010 events0 affected8,569 at risk
|